Maravai LifeSciences Holdings Total Liabilities 2019-2024 | MRVI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Maravai LifeSciences Holdings total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Maravai LifeSciences Holdings Total Liabilities 2019-2024 | MRVI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Maravai LifeSciences Holdings total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$205.5B
Stryker (SYK)	$138.7B
Boston Scientific (BSX)	$121.5B
Medtronic (MDT)	$113.7B
EssilorLuxottica (ESLOY)	$104.2B
Haleon (HLN)	$48.6B
Lonza Group Ag (LZAGY)	$45.9B
ResMed (RMD)	$36.9B
Koninklijke Philips (PHG)	$29.3B
Terumo (TRUMY)	$27.8B
Zimmer Biomet Holdings (ZBH)	$21.6B
Baxter (BAX)	$20.3B
Insulet (PODD)	$16.5B
Smith & Nephew SNATS (SNN)	$13.5B
Bio-Rad Laboratories (BIO)	$9.3B
Demant (WILYY)	$9.2B
BellRing Brands (BRBR)	$7.7B
Lantheus Holdings (LNTH)	$7.3B
ICU Medical (ICUI)	$4.3B
Haemonetics (HAE)	$3.9B
TG Therapeutics (TGTX)	$3.9B
GN Store Nord (GNNDY)	$3.8B
Perrigo (PRGO)	$3.8B
Neogen (NEOG)	$3.7B
Prestige Consumer Healthcare (PBH)	$3.6B
Envista Holdings (NVST)	$3.3B
QuidelOrtho (QDEL)	$3.1B
Agios Pharmaceuticals (AGIO)	$2.6B
Green Thumb Industries (GTBIF)	$2.2B
LeMaitre Vascular (LMAT)	$2B